On August 22, 2023 Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, reported that it will be presenting at the 8th CAR-TCR Summit in Boston from August 29 to September 1, 2023 (Press release, MediGene, AUG 22, 2023, View Source [SID1234634631]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
On August 30, 2023, Medigene’s CSO Prof. Schendel will present on the topic "Improving TCR-T Therapeutic Persistence & Efficacy with Switch Receptors" (see details below).
CAR-TCR Summit 2023
CAR-TCR Summit 2023
Date: August 30, 2023, 5:00 pm local time
Presenter: Prof. Dr. Dolores Schendel, CSO
Presentation: Improving TCR-T Therapeutics Persistence & Efficacy with Switch Receptors